摘要 : 2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1) is a novel antitumor diaziridinyl benzoquinone derivative designed to be bioactivated by the two-electron reductase NAD(P)H:quinone oxidoreductase (NQO1) and is cu... 展开
作者 | Yan C Kepa JK Siegel D Stratford IJ Ross D |
---|---|
作者单位 | |
期刊名称 | 《Molecular pharmacology》 |
总页数 | 9 |
语种/中图分类号 | 英语 / R9 |
关键词 | Antineoplastic Agents Aziridines Benzoquinones Cell Line Tumor Cytochromes b5 抗肿瘤药 氮丙啶类 苯醌类 NAD(P)H脱氢酶(醌) NADPH高铁血红素蛋白还原酶 |
馆藏号 | N2007EPST0000470 |